Description
Pramipexole (Prami) is a benzothiazole-derived compound that functions as a high-affinity D2-like dopamine receptor agonist, with selective binding to D2, D3, and D4 receptors. It exhibits high intrinsic activity at these receptor sites, influencing various dopaminergic signaling pathways.
This compound undergoes minimal hepatic metabolism, with primary clearance occurring via renal excretion in its unchanged form.